0179.KLSE Bioalpha Holdings Bhd
- Market cap
- MYR 28.4M
- P/E
- -
- P/B
- 0.44x
- ROE
- -15.5%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 0179.KLSE undervalued?
Graham numberThe Graham number of Bioalpha Holdings Bhd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bioalpha Holdings Bhd fundamental analysis
8 of 21 checks passedROE 0/2
Low return on equity (-15.5%), below 10%.
ROA 0/1
Return on assets (-13.7%) is below the industry median (4.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (39.0%) is above the industry median (-1.6%).
Revenue Growth 0/2
Revenue shrank 31.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.7%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Cash Runway 2/2
Cash covers 3.7 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.4x) is below the industry median (0.8x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Bioalpha Holdings Bhd
Bioalpha Holdings Berhad, an investment holding company, engages in the manufacture and sale of health supplement products in Malaysia, China, and internationally. The company operates through two segments, Trading and Manufacturing. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export, cultivation, manufacture, distribution, and trad…
Full company profileBioalpha Holdings Bhd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bioalpha Holdings Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 47.1M | 55.9M | 70.1M | 63.7M | 36.5M | 96.7M | 35.8M | 46.1M | 62.0M | 11.5M | 9.44M |
| Gross Profit | 19.5M | 22.0M | 30.6M | 25.2M | -10.9M | 14.1M | -5.98M | 124K | -3.78M | -916K | 722K |
| Operating Income | 7.91M | 9.56M | 15.0M | 11.1M | -40.9M | -2.58M | -48.1M | -44.6M | -57.5M | -33.7M | -11.1M |
| EBITDA | - | 17.0M | 24.0M | 22.7M | -27.6M | 10.4M | -35.5M | -33.1M | -46.2M | -27.9M | -5.88M |
| Net Income | 8.49M | 7.86M | 11.6M | 8.32M | -41.1M | -1.29M | -47.8M | -42.0M | -48.6M | -29.6M | -10.1M |
| EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.04 | 0.00 | -0.03 | -0.03 | -0.03 | -0.02 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 114M | 154M | 179M | 194M | 187M | 217M | 201M | 163M | 119M | 79.1M | 73.8M |
| Total Liabilities | 15.9M | 18.4M | 21.3M | 28.3M | 26.2M | 30.8M | 32.8M | 35.9M | 20.6M | 9.72M | 9.41M |
| Shareholders' Equity | 98.0M | 135M | 158M | 166M | 161M | 187M | 168M | 127M | 98.3M | 69.4M | 65.1M |
| Cash & Short-term Investments | 5.93M | 25.7M | 23.1M | 12.5M | 27.6M | 36.0M | 48.8M | 32.9M | 36.8M | 19.4M | 3.19M |
| Total Debt | 3.08M | 3.29M | 5.37M | 9.99M | 10.3M | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.00M | 40.4M | 20.5M | 16.3M | -1.64M | -3.71M | -5.37M | 2.44M | 88.9K | -11.7M | -644K |
| Capital Expenditure | 14.3M | 27.8M | 25.0M | 12.3M | 10.9M | 9.91M | 4.12M | 3.36M | 2.29M | 433K | 224K |
| Free Cash Flow | - | -7.61M | -14.8M | -8.72M | -20.3M | -19.5M | -19.7M | -2.13M | -2.20M | -6.26M | -868K |
| Ratios | |||||||||||
| ROE | 8.7% | 5.8% | 7.3% | 5.0% | -25.6% | -0.7% | -28.5% | -33.0% | -49.4% | -42.6% | -15.5% |
| ROA | 7.5% | 5.1% | 6.5% | 4.3% | -22.0% | -0.6% | -23.8% | -25.7% | -40.8% | -37.4% | -13.7% |
| Net Profit Margin | 18.0% | 14.1% | 16.5% | 13.1% | -112.8% | -1.3% | -133.6% | -91.1% | -78.3% | -257.8% | -106.7% |
| Debt to Equity | 0.03x | 0.02x | 0.03x | 0.06x | 0.06x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bioalpha Holdings Bhd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Sep 14, 2018
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | MYR 1.70M | 0.00 | 14.7% |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:3 on Sep 7, 2016.
Who owns Bioalpha Holdings Bhd
- Insiders 46.66%
- Institutions 13.42%
- Public & others 39.92%
- Shares outstanding 1.42B
- Free float 762M
Bioalpha Holdings Bhd company profile
- Company name
- Bioalpha Holdings Bhd
- Ticker
- 0179.KLSE
- ISIN
- MYQ0179OO000
- Exchange
- Kuala Lumpur Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- December
- Address
- No. 1, Jalan Perindustrian Suntrack, Bandar Baru Bangi, Malaysia, 43000
- Phone
- 60 3 8922 2286
- Website
- bioa.com.my
About Bioalpha Holdings Bhd
Bioalpha Holdings Berhad, an investment holding company, engages in the manufacture and sale of health supplement products in Malaysia, China, and internationally. The company operates through two segments, Trading and Manufacturing. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export, cultivation, manufacture, distribution, and trade of various agro products and medical herbs; and planting, growing, and trade of herbs, fruits, agricultural, and agro and organic products. In addition, the company is involved in the wholesale and retail trade of pharmaceutical and traditional medicines, healthcare, nutritional products, and food and beverages; procurement and sale of agricultural products; land development services; import and export of medicines and edible bacteria; sale of food through the internet; and management and consulting activities. Further, it operates pharmacy retail outlets under the Constant Pharmacy brand and concept shops, as well as acts as online trading agents and franchisors. The company was incorporated in 2005 and is headquartered in Bandar Baru Bangi, Malaysia.
Bioalpha Holdings Bhd management
10- Mr. Tze Hiung HoOperations Director · born 1977
- Mr. Kien Yoon KooExecutive Director · born 1977
- Dr. Keng How TanExecutive Director · born 1992
- Ms. Wan Joo AngExecutive Director · born 1992
- Ms. Siow Cheng GohFinancial Controller · born 1982
- Ms. Wai Cheng HowGroup Human Resources & Administrative Manager · born 1975
- Mr. Shahrizal Bin SharuddinRegulatory Compliance Manager · born 1981
- Mr. Chen Kong LowGroup General Manager · born 1973
- Ms. Ling Koon TangCompany Secretary
- Chyn Yuet WongCompany Secretary